A phase II study of durvalumab (MEDI4736) (anti-PDL1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

Johnson, B; Thomas, JV; Dasari, A; Raghav, KPS; Sanchez, EV; Kee, BK; Eng, C; Parseghian, CM; Morris, VK; Wolff, RA; Shureiqi, I; Kopetz, S; Overman, MJ

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索